Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01028222
Title A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
Acronym TEAM
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ITA | ESP | DEU | CAN | BEL | AUS

Facility Status City State Zip Country Details
City of Hope National Medical Center City of Hope national Med Ctr Duarte California 91010-3000 United States Details
University of California San Diego - Moores Cancer Center UCSD Moores Cancer Center La Jolla California 92093-0658 United States Details
University of California at Los Angeles UCLA Los Angeles California 90024 United States Details
California Pacific Medical Center California Pacific Med San Francisco California 94120-7999 United States Details
University of Colorado Univ Colorado 2 Aurora Colorado 80045 United States Details
Rush University Medical Center SC Chicago Illinois 60612 United States Details
Oncology Specialists, SC Dept.of Oncology Specialists Park Ridge Illinois 60068-0736 United States Details
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Medical Oncology Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute DFCI - Brookline Boston Massachusetts 02215 United States Details
Mayo Clinic - Rochester Mayo Clinic- Gonda Rochester Minnesota 55905 United States Details
Washington University School of Medicine CAMN107B2301 St. Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Case Western Reserve Case Western Cleveland Ohio 44106-5000 United States Details
Baylor Health Care System/Sammons Cancer Center Baylor 2 Dallas Texas 75246 United States Details
Novartis Investigative Site Buenos Aires C1125ABE Argentina Details
Novartis Investigative Site North Sydney New South Wales 2060 Australia Details
Novartis Investigative Site Adelaide South Australia 5000 Australia Details
Novartis Investigative Site East Melbourne Victoria 3002 Australia Details
Novartis Investigative Site Heidelberg Victoria 3084 Australia Details
Novartis Investigative Site Brussel 1090 Belgium Details
Novartis Investigative Site Bruxelles 1200 Belgium Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Belo Horizonte MG 30150-281 Brazil Details
Novartis Investigative Site Rio de Janeiro RJ 20230-130 Brazil Details
Novartis Investigative Site São Paulo SP 01246-000 Brazil Details
Novartis Investigative Site Toronto Ontario M4N 3M5 Canada Details
Novartis Investigative Site Toronto Ontario M5G 1Z5 Canada Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Erlangen 91054 Germany Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Köln 50937 Germany Details
Novartis Investigative Site Muenchen 80336 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Milano MI 20133 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Padova PD 35100 Italy Details
Novartis Investigative Site Siena SI 53100 Italy Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Nijmegen 6525 GA Netherlands Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site Hospitalet de LLobregat Cataluña 08907 Spain Details
Novartis Investigative Site Goteborg SE-413 45 Sweden Details
Novartis Investigative Site Malmö SE-205 02 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Uppsala SE-751 85 Sweden Details
Novartis Investigative Site Zürich 8091 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field